Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes
NHS hospitals in England used £40,857,410 of indicative cost of Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 8.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| South Warwickshire Nhs Foundation Trust | £2,458,315 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,024,621 |
| Salford Royal Nhs Foundation Trust | £1,215,202 |
| Aintree University Hospital Nhs Ft | £1,176,556 |
| Co.durham & Darlington Nhs Foundation Tr | £1,097,117 |
| Royal Free London Nhs Foundation Trust | £1,067,059 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,060,618 |
| East Sussex Healthcare Nhs Trust | £925,357 |
| Western Sussex Hospitals Nhs Found Trust | £910,328 |
| Barts Health Nhs Trust | £867,388 |
The primary-care picture
Ustekinumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ustekinumab medicine page.